We conducted an integrative analysis that incorporated PD-L1 expression, TMB, MSI status, immune-related and immune cell-type GEPs and measures of TILs from cohorts of TCGA database as well as internal data and patient tumor specimens from 3 hospitals. Here, CD274 is linked to neoplasm.